메뉴 건너뛰기




Volumn 38, Issue 2, 2017, Pages 693-702

Inhibition of the HDAC/Suv39/G9a pathway restores the expression of DNA damage-dependent major histocompatibility complex class I-related chain A and B in cancer cells

Author keywords

Chromatin remodeling; HDAC inhibitor; Immunotherapy; Ionizing radiation; NKG2D ligand

Indexed keywords

ACYLTRANSFERASE INHIBITOR; ATR PROTEIN; AZACITIDINE; CELL MEMBRANE PROTEIN; CHAETOCIN; DNA; HISTONE DEACETYLASE; HISTONE H3; HISTONE METHYLTRANSFERASE; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I RELATED CHAIN A; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I RELATED CHAIN B; METHYLTRANSFERASE INHIBITOR; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1,4 DIAZEPIN 1 YL) 6,7 DIMETHOXY 4 QUINAZOLINAMINE; NU 9056; PROTEIN G9A; PROTEIN P53; PROTEIN SUV39; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1; TRICHOSTATIN A; UNCLASSIFIED DRUG; VORINOSTAT; ZEBULARINE; ATM PROTEIN; ATR PROTEIN, HUMAN; E2F1 PROTEIN, HUMAN; EHMT2 PROTEIN, HUMAN; HISTOCOMPATIBILITY ANTIGEN; HISTONE LYSINE METHYLTRANSFERASE; HLA ANTIGEN CLASS 1; KLRK1 PROTEIN, HUMAN; METHYLTRANSFERASE; MHC CLASS I-RELATED CHAIN A; MICB ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; REPRESSOR PROTEIN; SUV39H1 PROTEIN, HUMAN;

EID: 85022007576     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2017.5773     Document Type: Article
Times cited : (27)

References (45)
  • 1
    • 84934287610 scopus 로고    scopus 로고
    • Therapeutic potential and challenges of natural killer cells in treatment of solid tumors
    • Gras Navarro A, Björklund AT and Chekenya M: Therapeutic potential and challenges of natural killer cells in treatment of solid tumors. Front Immunol 6: 202, 2015.
    • (2015) Front Immunol , vol.6 , pp. 202
    • Gras Navarro, A.1    Björklund, A.T.2    Chekenya, M.3
  • 4
    • 0033618504 scopus 로고    scopus 로고
    • Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
    • Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL and Spies T: Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729, 1999.
    • (1999) Science , vol.285 , pp. 727-729
    • Bauer, S.1    Groh, V.2    Wu, J.3    Steinle, A.4    Phillips, J.H.5    Lanier, L.L.6    Spies, T.7
  • 5
    • 68849105814 scopus 로고    scopus 로고
    • Oncogenic stress sensed by the immune system: Role of natural killer cell receptors
    • Raulet DH and Guerra N: Oncogenic stress sensed by the immune system: Role of natural killer cell receptors. Nat Rev Immunol 9: 568-580, 2009.
    • (2009) Nat Rev Immunol , vol.9 , pp. 568-580
    • Raulet, D.H.1    Guerra, N.2
  • 6
    • 84961879643 scopus 로고    scopus 로고
    • NKG2D receptor and its ligands in host defense
    • Lanier LL: NKG2D receptor and its ligands in host defense. Cancer Immunol Res 3: 575-582, 2015.
    • (2015) Cancer Immunol Res , vol.3 , pp. 575-582
    • Lanier, L.L.1
  • 7
    • 24144443517 scopus 로고    scopus 로고
    • The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
    • Gasser S, Orsulic S, Brown EJ and Raulet DH: The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436: 1186-1190, 2005.
    • (2005) Nature , vol.436 , pp. 1186-1190
    • Gasser, S.1    Orsulic, S.2    Brown, E.J.3    Raulet, D.H.4
  • 8
    • 77956911325 scopus 로고    scopus 로고
    • Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missingself recognition
    • Fine JH, Chen P, Mesci A, Allan DS, Gasser S, Raulet DH and Carlyle JR: Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missingself recognition. Cancer Res 70: 7102-7113, 2010.
    • (2010) Cancer Res , vol.70 , pp. 7102-7113
    • Fine, J.H.1    Chen, P.2    Mesci, A.3    Allan, D.S.4    Gasser, S.5    Raulet, D.H.6    Carlyle, J.R.7
  • 9
    • 65349131915 scopus 로고    scopus 로고
    • ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
    • Soriani A, Zingoni A, Cerboni C, Iannitto ML, Ricciardi MR, Di Gialleonardo V, Cippitelli M, Fionda C, Petrucci MT, Guarini A, et al: ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113: 3503-3511, 2009.
    • (2009) Blood , vol.113 , pp. 3503-3511
    • Soriani, A.1    Zingoni, A.2    Cerboni, C.3    Iannitto, M.L.4    Ricciardi, M.R.5    Di Gialleonardo, V.6    Cippitelli, M.7    Fionda, C.8    Petrucci, M.T.9    Guarini, A.10
  • 10
    • 84898035920 scopus 로고    scopus 로고
    • DNA double-strand break repair in a cellular context
    • Shibata A and Jeggo PA: DNA double-strand break repair in a cellular context. Clin Oncol 26: 243-249, 2014.
    • (2014) Clin Oncol , vol.26 , pp. 243-249
    • Shibata, A.1    Jeggo, P.A.2
  • 11
    • 0037365789 scopus 로고    scopus 로고
    • ATM and related protein kinases: Safeguarding genome integrity
    • Shiloh Y: ATM and related protein kinases: Safeguarding genome integrity. Nat Rev Cancer 3: 155-168, 2003.
    • (2003) Nat Rev Cancer , vol.3 , pp. 155-168
    • Shiloh, Y.1
  • 12
    • 62549156232 scopus 로고    scopus 로고
    • Changing of the guard: How ATM hands off DNA double-strand break signaling to ATR
    • Rhind N: Changing of the guard: How ATM hands off DNA double-strand break signaling to ATR. Mol Cell 33: 672-674, 2009.
    • (2009) Mol Cell , vol.33 , pp. 672-674
    • Rhind, N.1
  • 13
    • 79955460159 scopus 로고    scopus 로고
    • H3K9 methyltransferase G9a and the related molecule GLP
    • Shinkai Y and Tachibana M: H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev 25: 781-788, 2011.
    • (2011) Genes Dev , vol.25 , pp. 781-788
    • Shinkai, Y.1    Tachibana, M.2
  • 14
    • 0034056777 scopus 로고    scopus 로고
    • Structure-function analysis of SUV39H1 reveals a dominant role in heterochromatin organization, chromosome segregation, and mitotic progression
    • Melcher M, Schmid M, Aagaard L, Selenko P, Laible G and Jenuwein T: Structure-function analysis of SUV39H1 reveals a dominant role in heterochromatin organization, chromosome segregation, and mitotic progression. Mol Cell Biol 20: 3728-3741, 2000.
    • (2000) Mol Cell Biol , vol.20 , pp. 3728-3741
    • Melcher, M.1    Schmid, M.2    Aagaard, L.3    Selenko, P.4    Laible, G.5    Jenuwein, T.6
  • 15
    • 0035816682 scopus 로고    scopus 로고
    • Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3
    • Tachibana M, Sugimoto K, Fukushima T and Shinkai Y: Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J Biol Chem 276: 25309-25317, 2001.
    • (2001) J Biol Chem , vol.276 , pp. 25309-25317
    • Tachibana, M.1    Sugimoto, K.2    Fukushima, T.3    Shinkai, Y.4
  • 18
    • 84926347357 scopus 로고    scopus 로고
    • Pre-exposure to ionizing radiation stimulates DNA double strand break end resection, promoting the use of homologous recombination repair
    • Nakajima NI, Hagiwara Y, Oike T, Okayasu R, Murakami T, Nakano T and Shibata A: Pre-exposure to ionizing radiation stimulates DNA double strand break end resection, promoting the use of homologous recombination repair. PLoS One 10: e0122582, 2015.
    • (2015) PLoS One , vol.10 , pp. e0122582
    • Nakajima, N.I.1    Hagiwara, Y.2    Oike, T.3    Okayasu, R.4    Murakami, T.5    Nakano, T.6    Shibata, A.7
  • 19
    • 0033536068 scopus 로고    scopus 로고
    • Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB
    • Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH and Spies T: Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA 96: 6879-6884, 1999.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 6879-6884
    • Groh, V.1    Rhinehart, R.2    Secrist, H.3    Bauer, S.4    Grabstein, K.H.5    Spies, T.6
  • 20
    • 0034895155 scopus 로고    scopus 로고
    • Strategies for target cell recognition by natural killer cells
    • Diefenbach A and Raulet DH: Strategies for target cell recognition by natural killer cells. Immunol Rev 181: 170-184, 2001.
    • (2001) Immunol Rev , vol.181 , pp. 170-184
    • Diefenbach, A.1    Raulet, D.H.2
  • 21
    • 0036829733 scopus 로고    scopus 로고
    • Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: Analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity
    • Pende D, Rivera P, Marcenaro S, Chang CC, Biassoni R, Conte R, Kubin M, Cosman D, Ferrone S, Moretta L, et al: Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: Analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 62: 6178-6186, 2002.
    • (2002) Cancer Res , vol.62 , pp. 6178-6186
    • Pende, D.1    Rivera, P.2    Marcenaro, S.3    Chang, C.C.4    Biassoni, R.5    Conte, R.6    Kubin, M.7    Cosman, D.8    Ferrone, S.9    Moretta, L.10
  • 22
    • 79960812015 scopus 로고    scopus 로고
    • Understanding the limitations of radiation-induced cell cycle checkpoints
    • Deckbar D, Jeggo PA and Löbrich M: Understanding the limitations of radiation-induced cell cycle checkpoints. Crit Rev Biochem Mol Biol 46: 271-283, 2011.
    • (2011) Crit Rev Biochem Mol Biol , vol.46 , pp. 271-283
    • Deckbar, D.1    Jeggo, P.A.2    Löbrich, M.3
  • 26
    • 0042632901 scopus 로고    scopus 로고
    • Pathways of DNA double-strand break repair during the mammalian cell cycle
    • Rothkamm K, Krüger I, Thompson LH and Löbrich M: Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol 23: 5706-5715, 2003.
    • (2003) Mol Cell Biol , vol.23 , pp. 5706-5715
    • Rothkamm, K.1    Krüger, I.2    Thompson, L.H.3    Löbrich, M.4
  • 27
    • 34548779134 scopus 로고    scopus 로고
    • Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells
    • Kato N, Tanaka J, Sugita J, Toubai T, Miura Y, Ibata M, Syono Y, Ota S, Kondo T, Asaka M, et al: Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. Leukemia 21: 2103-2108, 2007.
    • (2007) Leukemia , vol.21 , pp. 2103-2108
    • Kato, N.1    Tanaka, J.2    Sugita, J.3    Toubai, T.4    Miura, Y.5    Ibata, M.6    Syono, Y.7    Ota, S.8    Kondo, T.9    Asaka, M.10
  • 29
    • 31344466008 scopus 로고    scopus 로고
    • DNA methylation and gene silencing in cancer
    • Baylin SB: DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2 (Suppl 1): S4-S11, 2005.
    • (2005) Nat Clin Pract Oncol , vol.2 , pp. S4-S11
    • Baylin, S.B.1
  • 30
    • 28244502269 scopus 로고    scopus 로고
    • Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B
    • Skov S, Pedersen MT, Andresen L, Straten PT, Woetmann A and Odum N: Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Res 65: 11136-11145, 2005.
    • (2005) Cancer Res , vol.65 , pp. 11136-11145
    • Skov, S.1    Pedersen, M.T.2    Andresen, L.3    Straten, P.T.4    Woetmann, A.5    Odum, N.6
  • 31
    • 22244485707 scopus 로고    scopus 로고
    • Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate
    • Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, et al: Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res 65: 6321-6329, 2005.
    • (2005) Cancer Res , vol.65 , pp. 6321-6329
    • Armeanu, S.1    Bitzer, M.2    Lauer, U.M.3    Venturelli, S.4    Pathil, A.5    Krusch, M.6    Kaiser, S.7    Jobst, J.8    Smirnow, I.9    Wagner, A.10
  • 32
    • 38949193232 scopus 로고    scopus 로고
    • NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class i specificities
    • Diermayr S, Himmelreich H, Durovic B, Mathys-Schneeberger A, Siegler U, Langenkamp U, Hofsteenge J, Gratwohl A, Tichelli A, Paluszewska M, et al: NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities. Blood 111: 1428-1436, 2008.
    • (2008) Blood , vol.111 , pp. 1428-1436
    • Diermayr, S.1    Himmelreich, H.2    Durovic, B.3    Mathys-Schneeberger, A.4    Siegler, U.5    Langenkamp, U.6    Hofsteenge, J.7    Gratwohl, A.8    Tichelli, A.9    Paluszewska, M.10
  • 33
    • 84871915611 scopus 로고    scopus 로고
    • RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry
    • Jung H, Hsiung B, Pestal K, Procyk E and Raulet DH: RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry. J Exp Med 209: 2409-2422, 2012.
    • (2012) J Exp Med , vol.209 , pp. 2409-2422
    • Jung, H.1    Hsiung, B.2    Pestal, K.3    Procyk, E.4    Raulet, D.H.5
  • 34
    • 36048958965 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: Overview and perspectives
    • Dokmanovic M, Clarke C and Marks PA: Histone deacetylase inhibitors: Overview and perspectives. Mol Cancer Res 5: 981-989, 2007.
    • (2007) Mol Cancer Res , vol.5 , pp. 981-989
    • Dokmanovic, M.1    Clarke, C.2    Marks, P.A.3
  • 35
    • 49849101700 scopus 로고    scopus 로고
    • Competitive or noncompetitive, that's the question: Research toward histone deacetylase inhibitors
    • Su H, Altucci L and You Q: Competitive or noncompetitive, that's the question: Research toward histone deacetylase inhibitors. Mol Cancer Ther 7: 1007-1012, 2008.
    • (2008) Mol Cancer Ther , vol.7 , pp. 1007-1012
    • Su, H.1    Altucci, L.2    You, Q.3
  • 36
    • 84920840486 scopus 로고    scopus 로고
    • Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid-Short Radiotherapy-Rectum 3rd trial)
    • Avallone A, Piccirillo MC, Delrio P, Pecori B, Di Gennaro E, Aloj L, Tatangelo F, D'Angelo V, Granata C, Cavalcanti E, et al: Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid-short Radiotherapy-rectum 3rd trial). BMC Cancer 14: 875, 2014.
    • (2014) BMC Cancer , vol.14 , pp. 875
    • Avallone, A.1    Piccirillo, M.C.2    Delrio, P.3    Pecori, B.4    Di Gennaro, E.5    Aloj, L.6    Tatangelo, F.7    D'Angelo, V.8    Granata, C.9    Cavalcanti, E.10
  • 37
    • 84933526775 scopus 로고    scopus 로고
    • Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): A phase 3, double-blind, randomised, placebo-controlled trial
    • Krug LM, Kindler HL, Calvert H, Manegold C, Tsao AS, Fennell D, Öhman R, Plummer R, Eberhardt WE, Fukuoka K, et al: Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): A phase 3, double-blind, randomised, placebo-controlled trial. Lancet Oncol 16: 447-456, 2015.
    • (2015) Lancet Oncol , vol.16 , pp. 447-456
    • Krug, L.M.1    Kindler, H.L.2    Calvert, H.3    Manegold, C.4    Tsao, A.S.5    Fennell, D.6    Öhman, R.7    Plummer, R.8    Eberhardt, W.E.9    Fukuoka, K.10
  • 38
    • 33747453473 scopus 로고    scopus 로고
    • Insulators: Exploiting transcriptional and epigenetic mechanisms
    • Gaszner M and Felsenfeld G: Insulators: Exploiting transcriptional and epigenetic mechanisms. Nat Rev Genet 7: 703-713, 2006.
    • (2006) Nat Rev Genet , vol.7 , pp. 703-713
    • Gaszner, M.1    Felsenfeld, G.2
  • 39
    • 84892942381 scopus 로고    scopus 로고
    • New and emerging HDAC inhibitors for cancer treatment
    • West AC and Johnstone RW: New and emerging HDAC inhibitors for cancer treatment. J Clin Invest 124: 30-39, 2014.
    • (2014) J Clin Invest , vol.124 , pp. 30-39
    • West, A.C.1    Johnstone, R.W.2
  • 42
    • 3042568739 scopus 로고    scopus 로고
    • Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor
    • Kim JH, Shin JH and Kim IH: Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor. Int J Radiat Oncol Biol Phys 59: 1174-1180, 2004.
    • (2004) Int J Radiat Oncol Biol Phys , vol.59 , pp. 1174-1180
    • Kim, J.H.1    Shin, J.H.2    Kim, I.H.3
  • 45
    • 84899063851 scopus 로고    scopus 로고
    • The anticancer effects of HDAC inhibitors require the immune system
    • West AC, Smyth MJ and Johnstone RW: The anticancer effects of HDAC inhibitors require the immune system. Oncoimmunology 3: e27414, 2014.
    • (2014) Oncoimmunology , vol.3 , pp. e27414
    • West, A.C.1    Smyth, M.J.2    Johnstone, R.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.